For 2016, analysts estimate sales to grow by 15% to $10.6 billion compared to the 9% growth in 2015. EBITDA is expected to grow by 13% to $4,212 million as compared to the 7.5% growth seen in 2015.
In the next few articles, we’ll discuss what led to these estimates, helping investors judge if analysts are being optimistic or conservative on the stock. We’ll also help you understand what may be priced into the stock.
For more industry updates, visit Market Realist’s pre-earnings analysis for Priceline’s rival Expedia (EXPE). We’ll also cover pre-earnings expectations for PCLN’s competitors TripAdvisor (TRIP) and Ctrip (CTRP). Check out Market Realist’s Online Travel page for the latest updates.
View more information: https://marketrealist.com/2016/07/what-do-analysts-recommend-for-priceline/